Carl L Gordon - Net Worth and Insider Trading
Carl L Gordon Net Worth
The estimated net worth of Carl L Gordon is at least $721 Million dollars as of 2025-05-07. Carl L Gordon is the Director, 10% Owner of Prevail Therapeutics Inc and owns about 13,822,463 shares of Prevail Therapeutics Inc (PRVL) stock worth over $318 Million. Carl L Gordon is the Director of Turning Point Therapeutics Inc and owns about 2,027,550 shares of Turning Point Therapeutics Inc (TPTX) stock worth over $154 Million. Carl L Gordon is also the Director, 10% Owner of Theseus Pharmaceuticals Inc and owns about 17,713,600 shares of Theseus Pharmaceuticals Inc (THRX) stock worth over $72 Million. Besides these, Carl L Gordon also holds MBX Biosciences Inc (MBX) , ArriVent BioPharma Inc (AVBP) , Compass Therapeutics Inc (CMPX) , Intellia Therapeutics Inc (NTLA) , Alector Inc (ALEC) , BioCryst Pharmaceuticals Inc (BCRX) , ORIC Pharmaceuticals Inc (ORIC) , ACADIA Pharmaceuticals Inc (ACAD) , Adicet Bio Inc (ACET) , Terns Pharmaceuticals Inc (TERN) , Keros Therapeutics Inc (KROS) , Kinnate Biopharma Inc (KNTE) , Cartesian Therapeutics Inc (RNAC) , X4 Pharmaceuticals Inc (XFOR) , Pacira BioSciences Inc (PCRX) . Details can be seen in Carl L Gordon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carl L Gordon has not made any transactions after 2025-04-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Carl L Gordon
Carl L Gordon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carl L Gordon owns 22 companies in total, including Prevail Therapeutics Inc (PRVL) , Turning Point Therapeutics Inc (TPTX) , and ORIC Pharmaceuticals Inc (ORIC) among others .
Click here to see the complete history of Carl L Gordon’s form 4 insider trades.
Insider Ownership Summary of Carl L Gordon
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
PRVL | Prevail Therapeutics Inc | 2020-06-17 | director & 10 percent owner |
TPTX | Turning Point Therapeutics Inc | 2019-04-22 | director |
ORIC | ORIC Pharmaceuticals Inc | 2021-03-30 | director |
![]() | ![]() | 2024-08-13 | director |
![]() | ![]() | 2019-09-12 | director & 10 percent owner |
![]() | ![]() | 2019-02-11 | director & 10 percent owner |
![]() | ![]() | 2018-06-22 | director |
![]() | ![]() | 2017-11-20 | director & 10 percent owner |
![]() | ![]() | 2016-05-11 | director & 10 percent owner |
![]() | ![]() | 2016-06-27 | director & 10 percent owner |
![]() | ![]() | 2013-09-18 | director |
![]() | ![]() | 2011-02-28 | director |
![]() | ![]() | 2011-02-08 | director |
![]() | ![]() | 2005-12-02 | director |
![]() | ![]() | 2005-04-20 | director |
![]() | ![]() | 2024-01-25 | director |
![]() | ![]() | 2025-04-09 | director & 10 percent owner |
![]() | ![]() | 2023-07-17 | director & 10 percent owner |
![]() | ![]() | 2023-05-05 | director |
![]() | ![]() | 2021-10-04 | director & 10 percent owner |
![]() | ![]() | 2024-07-16 | director & 10 percent owner |
![]() | ![]() | 2023-02-27 | 10 percent owner |
Carl L Gordon Latest Holdings Summary
Carl L Gordon currently owns a total of 18 stocks. Among these stocks, Carl L Gordon owns 13,822,463 shares of Prevail Therapeutics Inc (PRVL) as of June 24, 2019, with a value of $318 Million and a weighting of 44.11%. Carl L Gordon owns 2,027,550 shares of Turning Point Therapeutics Inc (TPTX) as of April 22, 2019, with a value of $154 Million and a weighting of 21.38%. Carl L Gordon also owns 17,713,600 shares of Theseus Pharmaceuticals Inc (THRX) as of July 17, 2023, with a value of $72 Million and a weighting of 9.98%. The other 15 stocks MBX Biosciences Inc (MBX) , ArriVent BioPharma Inc (AVBP) , Compass Therapeutics Inc (CMPX) , Intellia Therapeutics Inc (NTLA) , Alector Inc (ALEC) , BioCryst Pharmaceuticals Inc (BCRX) , ORIC Pharmaceuticals Inc (ORIC) , ACADIA Pharmaceuticals Inc (ACAD) , Adicet Bio Inc (ACET) , Terns Pharmaceuticals Inc (TERN) , Keros Therapeutics Inc (KROS) , Kinnate Biopharma Inc (KNTE) , Cartesian Therapeutics Inc (RNAC) , X4 Pharmaceuticals Inc (XFOR) , Pacira BioSciences Inc (PCRX) have a combined weighting of 24.53% among all his current holdings.
Latest Holdings of Carl L Gordon
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PRVL | Prevail Therapeutics Inc | 2019-06-24 | 13,822,463 | 23.00 | 317,916,649 |
TPTX | Turning Point Therapeutics Inc | 2019-04-22 | 2,027,550 | 76.01 | 154,114,076 |
THRX | Theseus Pharmaceuticals Inc | 2023-07-17 | 17,713,600 | 4.06 | 71,917,216 |
MBX | MBX Biosciences Inc | 2025-02-18 | 4,002,887 | 11.04 | 44,171,858 |
AVBP | ArriVent BioPharma Inc | 2024-01-30 | 1,513,664 | 20.08 | 30,394,373 |
CMPX | Compass Therapeutics Inc | 2025-04-09 | 15,219,994 | 1.75 | 26,709,567 |
NTLA | Intellia Therapeutics Inc | 2016-05-11 | 2,662,180 | 7.29 | 19,393,981 |
ALEC | Alector Inc | 2019-02-11 | 13,094,029 | 1.03 | 13,486,850 |
BCRX | BioCryst Pharmaceuticals Inc | 2005-12-02 | 1,100,000 | 9.99 | 10,989,000 |
ORIC | ORIC Pharmaceuticals Inc | 2021-03-30 | 2,212,571 | 4.77 | 10,542,901 |
ACAD | ACADIA Pharmaceuticals Inc | 2005-04-20 | 621,606 | 14.63 | 9,094,096 |
ACET | Adicet Bio Inc | 2024-01-25 | 11,447,140 | 0.54 | 6,181,456 |
TERN | Terns Pharmaceuticals Inc | 2024-07-16 | 755,635 | 3.09 | 2,331,134 |
KROS | Keros Therapeutics Inc | 2024-08-13 | 119,522 | 13.60 | 1,625,487 |
KNTE | Kinnate Biopharma Inc | 2023-05-05 | 450,000 | 2.65 | 1,192,500 |
RNAC | Cartesian Therapeutics Inc | 2016-06-27 | 60,847 | 10.41 | 633,113 |
XFOR | X4 Pharmaceuticals Inc | 2017-11-20 | 10,383 | 3.33 | 34,523 |
PCRX | Pacira BioSciences Inc | 2011-02-08 | 0 | 25.29 | 0 |
Holding Weightings of Carl L Gordon
Carl L Gordon Form 4 Trading Tracker
According to the SEC Form 4 filings, Carl L Gordon has made a total of 0 transactions in Prevail Therapeutics Inc (PRVL) over the past 5 years. The most-recent trade in Prevail Therapeutics Inc is the acquisition of 882,352 shares on June 24, 2019, which cost Carl L Gordon around $15 Million.
According to the SEC Form 4 filings, Carl L Gordon has made a total of 0 transactions in Turning Point Therapeutics Inc (TPTX) over the past 5 years. The most-recent trade in Turning Point Therapeutics Inc is the acquisition of 360,000 shares on April 22, 2019, which cost Carl L Gordon around $6 Million.
According to the SEC Form 4 filings, Carl L Gordon has made a total of 5 transactions in Theseus Pharmaceuticals Inc (THRX) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Theseus Pharmaceuticals Inc is the acquisition of 479,932 shares on July 17, 2023, which cost Carl L Gordon around $1 Million.
More details on Carl L Gordon's insider transactions can be found in the Insider Trading History of Carl L Gordon table.Insider Trading History of Carl L Gordon
- 1
Carl L Gordon Trading Performance
GuruFocus tracks the stock performance after each of Carl L Gordon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Carl L Gordon is 6.69%. GuruFocus also compares Carl L Gordon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Carl L Gordon within 3 months outperforms 15 times out of 30 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Carl L Gordon's insider trading performs compared to the benchmark.
Performance of Carl L Gordon
Carl L Gordon Ownership Network
Ownership Network List of Carl L Gordon
Ownership Network Relation of Carl L Gordon

Carl L Gordon Owned Company Details
What does Prevail Therapeutics Inc do?
Who are the key executives at Prevail Therapeutics Inc?
Carl L Gordon is the director & 10 percent owner of Prevail Therapeutics Inc. Other key executives at Prevail Therapeutics Inc include director & 10 percent owner Peter A. Thompson , General Counsel Kira M. Schwartz , and Chief Development Officer Franz Hefti .
Prevail Therapeutics Inc (PRVL) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Prevail Therapeutics Inc (PRVL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Prevail Therapeutics Inc (PRVL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Prevail Therapeutics Inc (PRVL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Prevail Therapeutics Inc Insider Transactions
Carl L Gordon Mailing Address
Above is the net worth, insider trading, and ownership report for Carl L Gordon. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Carl L Gordon's mailing address is: New York Ny 10022.